Fingerprint
Dive into the research topics of 'Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients with Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically